Disparities in cardiovascular diseases and risk factors across contexts and effectiveness of multicomponent intervention to enhance primary prevention.
Exploratie van de bijdrage van NAFLD (non-alcoholic fatty liver disease) en insulineresistentie in de ontwikkeling van cardiovasculaire complicaties bij mensen met type 1 diabetes.
Herorganiseren van de zorg rond het levenseinde voor patiënten met een aangeboren hartaandoening door trajecten naar de dood te identificeren en de curatieve en palliatieve zorg in het laatste jaar van het leven te evalueren
Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlle
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes Developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC)
European Society of Cardiology Quality Indicators for Cardiovascular Disease Prevention: developed by the Working Group for Cardiovascular Disease Prevention Quality Indicators in collaboration with the European Association for Preventive Cardiology of ..
European guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by re
Method of imaging a cardiovascular disease with an anti-macrophage mannose receptor immunoglobulin single variable domain